These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32252002)

  • 1. Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies.
    Weako J; Uba AI; Keskin Ö; Gürsoy A; Yelekçi K
    Comput Biol Chem; 2020 Jun; 86():107244. PubMed ID: 32252002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling.
    Albayati S; Uba AI; Yelekçi K
    Mol Divers; 2022 Apr; 26(2):1005-1016. PubMed ID: 33846894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.
    Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK
    ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
    Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox state.
    Frottin F; Bienvenut WV; Bignon J; Jacquet E; Vaca Jacome AS; Van Dorsselaer A; Cianferani S; Carapito C; Meinnel T; Giglione C
    Oncotarget; 2016 Sep; 7(39):63306-63323. PubMed ID: 27542228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity.
    Cornelius P; Mayes BA; Petersen JS; Turnquist DJ; Dufour PJ; Dannenberg AJ; Shanahan JM; Carver BJ
    Mol Cancer Ther; 2024 May; 23(5):595-605. PubMed ID: 38530115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cis-fumagillin, a new methionine aminopeptidase (type 2) inhibitor produced by Penicillium sp. F2757.
    Kwon JY; Jeong HW; Kim HK; Kang KH; Chang YH; Bae KS; Choi JD; Lee UC; Son KH; Kwon BM
    J Antibiot (Tokyo); 2000 Aug; 53(8):799-806. PubMed ID: 11079802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
    Wang J; Lou P; Henkin J
    J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
    Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
    Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
    Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
    Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
    Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
    J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4.
    Endo H; Takenaga K; Kanno T; Satoh H; Mori S
    J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites of PPI-2458, a selective, irreversible inhibitor of methionine aminopeptidase-2: structure determination and in vivo activity.
    Arico-Muendel CC; Belanger B; Benjamin D; Blanchette HS; Caiazzo TM; Centrella PA; DeLorey J; Doyle EG; Gradhand U; Griffin ST; Hill S; Labenski MT; Morgan BA; O'Donovan G; Prasad K; Skinner S; Taghizadeh N; Thompson CD; Wakefield J; Westlin W; White KF
    Drug Metab Dispos; 2013 Apr; 41(4):814-26. PubMed ID: 23355637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.
    Sheppard GS; Wang J; Kawai M; BaMaung NY; Craig RA; Erickson SA; Lynch L; Patel J; Yang F; Searle XB; Lou P; Park C; Kim KH; Henkin J; Lesniewski R
    Bioorg Med Chem Lett; 2004 Feb; 14(4):865-8. PubMed ID: 15012983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition.
    Warder SE; Tucker LA; McLoughlin SM; Strelitzer TJ; Meuth JL; Zhang Q; Sheppard GS; Richardson PL; Lesniewski R; Davidsen SK; Bell RL; Rogers JC; Wang J
    J Proteome Res; 2008 Nov; 7(11):4807-20. PubMed ID: 18828628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression.
    Hu X; Addlagatta A; Lu J; Matthews BW; Liu JO
    Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18148-53. PubMed ID: 17114291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors.
    Hou YP; Sun J; Pang ZH; Lv PC; Li DD; Yan L; Zhang HJ; Zheng EX; Zhao J; Zhu HL
    Bioorg Med Chem; 2011 Oct; 19(20):5948-54. PubMed ID: 21925884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides.
    Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE
    Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers.
    Shimizu H; Yamagishi S; Chiba H; Ghazizadeh M
    Adv Clin Exp Med; 2016; 25(1):117-28. PubMed ID: 26935506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine aminopeptidase 2 and cancer.
    Selvakumar P; Lakshmikuttyamma A; Dimmock JR; Sharma RK
    Biochim Biophys Acta; 2006 Apr; 1765(2):148-54. PubMed ID: 16386852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.